Patrick Lin is Chief Business - Strategy Off at Processa Pharmaceuticals, Inc. (PCSA). They have made 16 open-market trades across 1 company since 2020, most recently 2026-06-30.
CIK 0001799363
16 open-market purchases totalling $274K since 2020, never a sale. Across 16 scored buys the stock is down 12.1% at ninety days, and 13.5 points behind the S&P over the same stretch.
16 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| PCSA | 13,113 | $22K |
Shares reported on the most recent Form 4, priced at the 2026-07-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 44% | 44% | 19% |
| Avg Move | +1.6% | -4.1% | -12.1% |
| Alpha | +0.9% | -4.5% | -13.5% |
| Scored | 16 | 16 | 16 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCSA | BUY | 2026-06-30 | 2026-07-01 | $1.93 | $4K | +7.5% | +0.9% | -14.6% |
| PCSA | BUY | 2026-06-15 | 2026-06-16 | $2.22 | $4K | -7.5% | +5.7% | -10.4% |
| PCSA | BUY | 2026-05-29 | 2026-06-01 | $2.57 | $4K | -6.2% | -23.7% | -20.6% |
| PCSA | BUY | 2026-05-15 | 2026-05-19 | $2.97 | $4K | -2.7% | -18.4% | -18.0% |
| PCSA | BUY | 2026-04-30 | 2026-05-01 | $2.69 | $4K | -6.6% | -7.3% | -25.5% |
| PCSA | BUY | 2026-04-15 | 2026-04-17 | $2.97 | $4K | -17.2% | -16.9% | -32.3% |
| PCSA | BUY | 2026-03-31 | 2026-04-01 | $2.54 | $4K | +0.0% | -4.5% | -34.0% |
| PCSA | BUY | 2025-01-27 | 2025-01-29 | $0.80 | $35K | -9.7% | -21.5% | -67.2% |
| PCSA | BUY | 2024-01-31 | 2024-02-01 | $2.38 | $10K | -3.3% | +3.7% | -8.3% |
| PCSA | BUY | 2022-05-17 | 2022-05-19 | $1.59 | $3K | +14.5% | +24.7% | +37.9% |
| PCSA | BUY | 2022-04-06 | 2022-04-08 | $3.29 | $7K | -8.0% | -35.8% | +2.5% |
| PCSA | BUY | 2021-12-14 | 2021-12-16 | $4.00 | $12K | +11.0% | -4.8% | -28.0% |
| PCSA | BUY | 2021-12-03 | 2021-12-07 | $4.80 | $17K | +15.1% | +10.3% | -18.6% |
| PCSA | BUY | 2021-08-26 | 2021-08-30 | $6.02 | $24K | +18.8% | +29.7% | -13.4% |
| PCSA | BUY | 2021-06-21 | 2021-06-22 | $6.65 | $13K | +8.1% | -8.0% | -2.4% |
| PCSA | BUY | 2020-10-01 | 2020-10-05 | $4.00 | $125K | +12.0% | +1.0% | +59.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.